Argent BioPharma Limited (ASX:RGT)

Australia · Delayed Price · Currency is AUD

0.0320

+0.0020 (6.67%)

Sep 4, 2026, 3:58 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Pharmaceuticals			891.08K	3.39M	-	-	2.08M
Total			891.08K	3.39M	-	-	2.08M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Slovenia and Others			440.44K	2.85M	3.22M	1.09M	1.94M
Malta			13.21K	-	-	-	-
Australia and Others			-	-	1.06M	-	-
Australia			437.43K	533.54K	-	1.65M	140.74K
Israel			-	7.10K	456.60K	255.10K	-
Total			891.08K	3.39M	4.73M	3.00M	2.08M